WASHINGTON (Reuters) - Healthcare company Abbott Laboratories ABT.N has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc STJ.N, the U.S. Federal Trade Commission said on Tuesday.